Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling

作者：Guangchao Pan, Mengya Zhong, Jingwei Yao, Jinshui Tan, Huijian Zheng, Yuelong Jiang, Yuanfang Tang, Yuanfang Tang, Hui Zhou, Dongmei Qin, Xingxing Yu, Zhifeng Li, Zhijuan Lin, Zhijuan Lin, Yirong Jiang, Yirong Jiang, Bing Xu, Jie Zha · 发表于：Journal of Cancer Research and Clinical Oncology · 年份：2022 · DOI：10.1007/s00432-022-04473-5 · 被引用次数：8 · 研究领域：Chronic Lymphocytic Leukemia Research、Lymphoma Diagnosis and Treatment、Protein Degradation and Inhibitors